Haleon (NYSE:HLN) Downgraded to Hold Rating by Hsbc Global Res

Haleon (NYSE:HLN) was downgraded by stock analysts at Hsbc Global Res from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Wednesday,Zacks.com reports.

Other research analysts also recently issued research reports about the stock. Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. HSBC reissued a “hold” rating on shares of Haleon in a report on Wednesday. Finally, Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Five research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $10.95.

Haleon Stock Down 1.2 %

HLN stock opened at $10.55 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The business has a 50 day moving average of $9.63 and a 200 day moving average of $9.85. Haleon has a twelve month low of $7.89 and a twelve month high of $10.80. The firm has a market cap of $47.74 billion, a PE ratio of 31.01, a price-to-earnings-growth ratio of 2.82 and a beta of 0.28.

Haleon (NYSE:HLN) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The firm had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. On average, research analysts forecast that Haleon will post 0.43 EPS for the current fiscal year.

Hedge Funds Weigh In On Haleon

A number of institutional investors and hedge funds have recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC lifted its holdings in Haleon by 3.0% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 61,016 shares of the company’s stock valued at $646,000 after acquiring an additional 1,766 shares during the period. Farther Finance Advisors LLC lifted its stake in shares of Haleon by 33.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 10,936 shares of the company’s stock worth $116,000 after purchasing an additional 2,715 shares during the period. Janney Montgomery Scott LLC boosted its holdings in shares of Haleon by 13.9% in the third quarter. Janney Montgomery Scott LLC now owns 750,897 shares of the company’s stock worth $7,944,000 after buying an additional 91,610 shares during the last quarter. QRG Capital Management Inc. grew its position in Haleon by 20.9% during the third quarter. QRG Capital Management Inc. now owns 201,934 shares of the company’s stock valued at $2,136,000 after buying an additional 34,884 shares during the period. Finally, Portside Wealth Group LLC increased its holdings in Haleon by 4.5% during the third quarter. Portside Wealth Group LLC now owns 47,003 shares of the company’s stock valued at $497,000 after buying an additional 2,018 shares during the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.